Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer

Share this content:
Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer
 
Sponsor
BioCis Pharma Ltd.

Collaborators
Turku University Hospital
Tampere University Hospital
FinnMedi Oy
 
Principal Investigator
Juha Peltonen, MD
CRST (Clinical Research Services Turku)

Contacts
Lasse Leino, PhD
358 40 849 4694
lasse.leino@biocis.com

Jarmo Laihia, PhD
358 40 865 1616
jarmo.laihia@biocis.com
 
ClinicalTrials.gov Identifier
NCT01458847

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.